Finance

Lists
Why is MDCX up 14.82%?
Dive Deeper
MDCX:NASDAQ
Medicus Pharma Ltd
$1.97
+14.82%
(+0.25) 1D
Nov 13, 10:32:38 AM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for MDCX...
Open
$1.75
High
$1.97
Low
$1.70
Mkt. cap
3.80M
Avg. vol.
85.80K
Volume
9.29K
52-wk high
$127.50
52-wk low
$1.63
EPS
-$122.54
Shares outstanding
1.92M
No. of employees
16
Open
$1.75
High
$1.97
Low
$1.70
Mkt. cap
3.80M
Avg. vol.
85.80K
Volume
9.29K
52-wk high
$127.50
52-wk low
$1.63
EPS
-$122.54
Shares outstanding
1.92M
No. of employees
16
News stories
From web sources and news partners
About Medicus Pharma Ltd
CEO-
Employees16
Founded2008
HeadquartersConshohocken, Pennsylvania, United States
SectorHealth Care
IndustryBiotechnology
Websitemedicuspharma.com
Analyst ratings
Based on 4 analysts giving stock ratings to MDCX in the past 3 months
Strong buy
Buy
3
Hold
1
Sell
0
12-month forecast
Based on 4 Wall Street analysts offering 12 month price targets for MDCX in the last 3 months.
Highest
Current $1.97
$450.00 (+22,685.96%)
Average
$171.67 (+8,592.59%)
Lowest
$15.00 (+659.53%)
Analyst
Recommendation
Action
Price target
Projected
Date
Kumaraguru Raja
Brookline Capital Markets
Hold
Downgraded
-
-
11/11/2026
Jason McCarthy
Maxim Group
Buy
Maintained
$15.00
+659.5%
11/09/2026
Matthew Venezia
Alliance Global Partners
Buy
Maintained
$50.00
+2,431.8%
09/14/2026
Scott Henry
Alliance Global Partners
Buy
Maintained
$1.00
-49.4%
09/14/2026
Jonathan Aschoff
Roth MKM
Buy
Maintained
$450.00
+22,686%
09/09/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
2.59M
2.70M
4.91M
1.95M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
5.20M
5.89M
6.57M
2.51M
Operating expense
7.79M
8.60M
11.48M
4.46M
Total operating expenses
7.79M
8.60M
11.48M
4.46M
Operating income
-7.79M
-8.60M
-11.48M
-4.46M
Other non operating income
-6.88M
-
-
-
EBT including unusual items
-15.07M
-9.04M
-11.68M
-15.17M
EBT excluding unusual items
-14.95M
-8.92M
-11.68M
-5.17M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-15.07M
-9.04M
-11.62M
-15.18M
Net profit margin
-
-
-
-
Earnings per share
-22.21
-15.09
-10.50
-11.64
Interest and investment income
-
56.56K
-
-
Interest expense
-272.82K
-374.71K
-205.64K
-712.65K
Net interest expenses
-272.82K
-318.15K
-205.64K
-712.65K
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps